David S. Romeo

Array ( [id] => 5289954 [patent_doc_number] => 20090022684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'Methods for hematopoietic stimulation' [patent_app_type] => utility [patent_app_number] => 11/800991 [patent_app_country] => US [patent_app_date] => 2007-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9110 [patent_no_of_claims] => 135 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20090022684.pdf [firstpage_image] =>[orig_patent_app_number] => 11800991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5011411 [patent_doc_number] => 20070281890 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-06 [patent_title] => 'Fibroblast Growth Factor-13' [patent_app_type] => utility [patent_app_number] => 11/738563 [patent_app_country] => US [patent_app_date] => 2007-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 27448 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20070281890.pdf [firstpage_image] =>[orig_patent_app_number] => 11738563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5355474 [patent_doc_number] => 20090186818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-23 [patent_title] => 'Therapeutic Method for Glycaemic Control' [patent_app_type] => utility [patent_app_number] => 12/296716 [patent_app_country] => US [patent_app_date] => 2007-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5286 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20090186818.pdf [firstpage_image] =>[orig_patent_app_number] => 12296716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5188448 [patent_doc_number] => 20070166756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-19 [patent_title] => 'Polypeptides and polynucleotides encoding same' [patent_app_type] => utility [patent_app_number] => 11/724656 [patent_app_country] => US [patent_app_date] => 2007-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 35960 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20070166756.pdf [firstpage_image] =>[orig_patent_app_number] => 11724656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5465671 [patent_doc_number] => 20090325871 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'Role of the Mk2 Pathway in Wound Repair' [patent_app_type] => utility [patent_app_number] => 12/224865 [patent_app_country] => US [patent_app_date] => 2007-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 6690 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0325/20090325871.pdf [firstpage_image] =>[orig_patent_app_number] => 12224865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5220257 [patent_doc_number] => 20070161568 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-12 [patent_title] => 'Use of GLP-1 peptides' [patent_app_type] => utility [patent_app_number] => 11/714000 [patent_app_country] => US [patent_app_date] => 2007-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5238 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20070161568.pdf [firstpage_image] =>[orig_patent_app_number] => 11714000 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4705109 [patent_doc_number] => 20080064633 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-13 [patent_title] => 'Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions' [patent_app_type] => utility [patent_app_number] => 11/711405 [patent_app_country] => US [patent_app_date] => 2007-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12117 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20080064633.pdf [firstpage_image] =>[orig_patent_app_number] => 11711405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5045582 [patent_doc_number] => 20070264255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'Antibodies to TGF-beta' [patent_app_type] => utility [patent_app_number] => 11/700684 [patent_app_country] => US [patent_app_date] => 2007-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 21021 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20070264255.pdf [firstpage_image] =>[orig_patent_app_number] => 11700684 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5252790 [patent_doc_number] => 20070134246 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Antibodies to TGF-BETA' [patent_app_type] => utility [patent_app_number] => 11/700711 [patent_app_country] => US [patent_app_date] => 2007-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 21022 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20070134246.pdf [firstpage_image] =>[orig_patent_app_number] => 11700711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5247811 [patent_doc_number] => 20070244045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => 'Treatment of Acute Respiratory Distress Syndrome' [patent_app_type] => utility [patent_app_number] => 11/626128 [patent_app_country] => US [patent_app_date] => 2007-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4820 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20070244045.pdf [firstpage_image] =>[orig_patent_app_number] => 11626128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5473042 [patent_doc_number] => 20090246208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'METHODS FOR PREVENTING AND TREATING CANCER METASTASIS AND BONE LOSS ASSOCIATED WITH CANCER METASTASIS' [patent_app_type] => utility [patent_app_number] => 12/159665 [patent_app_country] => US [patent_app_date] => 2007-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 22871 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20090246208.pdf [firstpage_image] =>[orig_patent_app_number] => 12159665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5271074 [patent_doc_number] => 20090074850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'USE OF A TOPICAL COMPOSITION CONTAINING EPIDERMAL GROWTH FACTOR (EGF) FOR DIABETIC FOOT AMPUTATION PREVENTION' [patent_app_type] => utility [patent_app_number] => 12/159159 [patent_app_country] => US [patent_app_date] => 2006-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6833 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20090074850.pdf [firstpage_image] =>[orig_patent_app_number] => 12159159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 204985 [patent_doc_number] => 07629446 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-08 [patent_title] => 'Nucleic acid molecules encoding a novel ectoparasite saliva protein' [patent_app_type] => utility [patent_app_number] => 11/611011 [patent_app_country] => US [patent_app_date] => 2006-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 44214 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/629/07629446.pdf [firstpage_image] =>[orig_patent_app_number] => 11611011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6529028 [patent_doc_number] => 20100015164 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'Compositions and Methods for Modulating Osteoblast Cell Differentiation and Bone Generation Through HIF-1a' [patent_app_type] => utility [patent_app_number] => 12/096733 [patent_app_country] => US [patent_app_date] => 2006-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14366 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20100015164.pdf [firstpage_image] =>[orig_patent_app_number] => 12096733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5171817 [patent_doc_number] => 20070072249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-29 [patent_title] => 'Human cytokine and alpha-helix-containing polypeptides' [patent_app_type] => utility [patent_app_number] => 11/634751 [patent_app_country] => US [patent_app_date] => 2006-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35234 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20070072249.pdf [firstpage_image] =>[orig_patent_app_number] => 11634751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5285423 [patent_doc_number] => 20090099098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'PEPTIDE SUBSTANCE ENHANCING CAPILLARIES RESISTANCE, PHARMACEUTICAL COMPOSITION ON ITS BASE AND METHOD OF ITS APPLICATION' [patent_app_type] => utility [patent_app_number] => 12/298411 [patent_app_country] => US [patent_app_date] => 2006-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5686 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20090099098.pdf [firstpage_image] =>[orig_patent_app_number] => 12298411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5501657 [patent_doc_number] => 20090162345 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'Materials and Methods for Reversing Type-1 Diabetes' [patent_app_type] => utility [patent_app_number] => 12/094866 [patent_app_country] => US [patent_app_date] => 2006-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11856 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20090162345.pdf [firstpage_image] =>[orig_patent_app_number] => 12094866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5410045 [patent_doc_number] => 20090123944 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'Bioassays' [patent_app_type] => utility [patent_app_number] => 12/094660 [patent_app_country] => US [patent_app_date] => 2006-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6256 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20090123944.pdf [firstpage_image] =>[orig_patent_app_number] => 12094660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5106578 [patent_doc_number] => 20070065455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'Eta-1 gene and methods for use' [patent_app_type] => utility [patent_app_number] => 11/603484 [patent_app_country] => US [patent_app_date] => 2006-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 26341 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20070065455.pdf [firstpage_image] =>[orig_patent_app_number] => 11603484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4853117 [patent_doc_number] => 20080318860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'High Activity Growth Factor Mutants' [patent_app_type] => utility [patent_app_number] => 12/094227 [patent_app_country] => US [patent_app_date] => 2006-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8116 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20080318860.pdf [firstpage_image] =>[orig_patent_app_number] => 12094227 [rel_patent_id] =>[rel_patent_doc_number] =>)